Skip to content

Efficacy and safety of magnesium sulfate in maintaining intraoperative hemodynamic stability in patients with pheochromocytoma and paraganglioma: a randomized, double-blind, placebo-controlled study

Efficacy and safety of magnesium sulfate in maintaining intraoperative hemodynamic stability in patients with pheochromocytoma and paraganglioma: a randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046067
Enrollment
Unknown
Registered
2021-05-03
Start date
2021-05-27
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pheochromocytoma and paraganglioma

Interventions

Intervention Group:Magnesium sulphate
Control Group:0.9% saline

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Clinically diagnosed as resectable pheochromocytoma or paraganglioma that may be resected, elective surgical resection is planned; 3. Before operation, prepare for operation with a-receptor blocker, and the medication time is more than 7 days; 4. Preoperative preparation is sufficient, blood pressure is controlled below 140/90mmHg, and heart rate is controlled below 90 beats/min.

Exclusion criteria

Exclusion criteria: 1. Severe liver dysfunction (Child-Pugh grade C) or renal failure (requires renal replacement therapy) before surgery; 2. Allergic to study drugs; 3. There is hypermagnesemia before the operation; 4. The attending doctor or researcher believes that there are other situations that are not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Intraoperative hemodynamic instability;

Secondary

MeasureTime frame
Total amount of phentolamine, esmolol and catecholamine infusions during surgery;Blood catecholamine concentration measured during surgery;Proportion of prolonged hypotension after surgery;Complications within 30 days after surgery;Maximum SBP;Minimum MAP;Maximum HR;

Countries

China

Contacts

Public ContactKong Hao

Peking University First Hospital

konghao2438@126.com+86 18611041430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026